Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Free Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07120529
What this trial is testing

Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.

Who this might be right for
Cervical CancerHysterectomy
Medical University of Silesia 300
Not applicableEnded earlyNCT03412630
What this trial is testing

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
ECOG-ACRIN Cancer Research Group 1
Not applicableLooking for participantsNCT06088134
What this trial is testing

Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Clear Cell Renal Cell CarcinomaPrognostic Cancer ModelRecurrent Renal Cell Cancer
Mingzhao Xiao 800
Post-approval studies (Phase 4)WithdrawnNCT06390111
What this trial is testing

A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose.

Who this might be right for
Bladder CancerTa/T1CIS
Ferring Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT07175480
What this trial is testing

PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Renal Cell Carcinoma (mRCC)
Jinling Hospital, China 30
Not applicableUnknownNCT04245410
What this trial is testing

Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma

Who this might be right for
Surgical ProcedureDisease Free SurvivalOverall Survival
Universidad de Extremadura 100
Post-approval studies (Phase 4)UnknownNCT06521697
What this trial is testing

Effects of Minimal-Flow Sevoflurane and Multimodal Analgesia in Head and Neck Cancer Surgery

Who this might be right for
Head and Neck CancerAnesthesiaRenal Protection+2 more
National Taiwan University Hospital 60
Not applicableLooking for participantsNCT07657325
What this trial is testing

Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)
Tianjin Medical University Second Hospital 110
Not applicableApproved For MarketingNCT03079687
What this trial is testing

Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Who this might be right for
Ovarian Cancer
AstraZeneca
Not applicableStudy completedNCT00620984
What this trial is testing

Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis

Who this might be right for
MastitisStaphylococcus AureusStaphylococcal Infections
State University of New York - Upstate Medical University 557
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Testing effectiveness (Phase 2)Study completedNCT00776074
What this trial is testing

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Who this might be right for
Uterine Fibroids
Takeda 80
Not applicableStudy completedNCT07827482
What this trial is testing

Pretreatment 18F-FDG PET/CT Radiomics for Predicting Response to First-Line Targeted Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
First Affiliated Hospital of Fujian Medical University 228
Testing effectiveness (Phase 2)WithdrawnNCT02053597
What this trial is testing

TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen

Who this might be right for
Breast Cancer
Jules Bordet Institute
Not applicableNot Yet RecruitingNCT07764341
What this trial is testing

Supervised Exercise During Neoadjuvant Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Neoplasm Malignant Female
King Hamad University Hospital, Bahrain 80
Large-scale testing (Phase 3)Study completedNCT01258413
What this trial is testing

Laparoscopic vs Abdominal Radical Hysterectomy In Patients With Early Cervical Cancer

Who this might be right for
Cervical CancerPostoperative Pain
Hospital Nossa Senhora da Conceicao 30
Very early researchEnded earlyNCT03266900
What this trial is testing

A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival

Who this might be right for
Bladder CancerBladder Urothelial Carcinoma
University Health Network, Toronto 2
Not applicableStudy completedNCT06631066
What this trial is testing

Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients

Who this might be right for
Breast Cancer Female
National Cancer Institute, Egypt 160
Large-scale testing (Phase 3)Study completedNCT03106987
What this trial is testing

Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.

Who this might be right for
Epithelial Ovarian Cancer
AstraZeneca 220
Not applicableUnknownNCT03967457
What this trial is testing

Comprehensive Study on the Quality of Life in Cervical Cancer Patients

Who this might be right for
Quality of LifeCervical CancerUrodynamics+7 more
Lei Li 10,000
Next Page